CrossRef From liver to gut: the hidden gastrointestinal impact of pediatric metabolic dysfunction-associated steatotic liver disease Gianmario Forcina, Vittoria Frattolillo, Maria De Cesare, Assunta Floriano, Rosamaria Palma, Federica Casamassima, Mario Bartiromo, Pierluigi Marzuillo, Emanuele Miraglia del Giudice, Anna Di Sessa Expert Review of Gastroenterology & Hepatology .2025
Conclusion DNA tests offer potential insights about your reaction to GLP-1 medications which can help you and your doctor improve your treatment choices
Researchers familiar with preparing any injectable peptide will find nothing new here
Management options include dose reduction of the GLP-1 receptor agonist, switching to an alternative agent in the class, or temporarily discontinuing therapy to assess whether heart rate normalizes